| 1 |
Xiao B, Zhang W, Chen L, et al. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data [J]. Gene, 2018, 658: 28-35.
|
| 2 |
Spizzo R, Almeida MI, Colombatti A, et al. Long non-coding RNAs and cancer: a new frontier of translational research? [J]. Oncogene, 2012, 31(43): 4577-4587.
|
| 3 |
Pan X, Zhang G, Gao C. LncRNA PVT1: a novel therapeutic target for cancers [J].Clin Lab, 2018, 64(5): 655-662.
|
| 4 |
Sartori DA, Chan DW. Biomarkers in prostate cancer: what′s new? [J]. Curr Opin Oncol, 2014, 26(3): 259-264.
|
| 5 |
Ren S, Wang F, Shen J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer [J]. Eur J Cancer, 2013, 49(13): 2949-2959.
|
| 6 |
Dong L, Lin W, Qi P, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer [J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(7): 1158-1166.
|
| 7 |
Gezer U, özgür E, Cetinkaya M, et al. Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes [J]. Cell Biol Int, 2014, 38(9): 1076-1079.
|
| 8 |
Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives [J]. Mol Cancer, 2016, 15(1): 39.
|
| 9 |
Xie H, Ma H, Zhou D.Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma [J]. Biomed Res Int, 2013, 2013: 136106.
|
| 10 |
Tang J, Jiang R, Deng L, et al. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma [J]. Oncotarget, 2015, 6(6): 4505-4515.
|
| 11 |
Zhou X, Yin C, Dang Y, et al. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer [J]. Sci Rep, 2015, 5: 11516.
|
| 12 |
Li Q, Shao Y, Zhang X, et al. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer [J]. Tumour Biol, 2015, 36(3): 2007- 2012.
|
| 13 |
Pang Q, Ge J, Shao Y, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance [J]. Tumour Biol, 2014, 35(6): 5441- 5447.
|
| 14 |
Zhang K, Shi H, Xi H, et al. Genome-wide lncRNA microarray profiling identifies novel circulating lncRNAs for detection of gastric cancer [J]. Theranostics, 2017, 7(1): 213-227.
|
| 15 |
Dong L, Qi P, Xu MD, et al. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls [J]. Int J Cancer, 2015, 137 (5): 1128-1135.
|
| 16 |
Zhang J, Zhang B, Wang T,et al. LncRNA MALAT1 overexpression is an unfavorable prognostic factor in human cancer: evidence from a meta-analysis [J]. Int J Clin Exp Med, 2015, 8 (4): 5499-5505.
|
| 17 |
Guo F, Yu F, Wang J, et al. Expression of MALAT1 in the peripheral whole blood of patients with lung cancer [J]. Biomed Rep, 2015, 3(3): 309-312.
|
| 18 |
Weber DG, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer [J]. BMC Res Notes, 2013, 6: 518.
|
| 19 |
Shao Y, Ye M, Jiang X, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer [J]. Cancer, 2014, 120(21): 3320-3328.
|
| 20 |
Xue WJ, Ying XL, Jiang JH, et al. Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis [J]. J Cancer Res Ther, 2014, 10 Suppl: C218-C221.
|
| 21 |
Wang F, Ren S, Chen R, et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer [J]. Oncotarget, 2014, 5(22): 11091-11102.
|
| 22 |
Tong YS, Wang XW, Zhou XL, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma [J]. Mol Cancer, 2015, 14: 3.
|
| 23 |
Han Y, Liu Y, Gui Y, et al. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder [J]. J Surg Oncol, 2013, 107(5): 555-559.
|
| 24 |
Svoboda M, Slyskova J, Schneiderova M, et al. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients [J]. Carcinogenesis, 2014, 35(7): 1510-1515.
|
| 25 |
Tang H, Wu Z, Zhang J, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis [J]. Mol Med Rep, 2013, 7(3): 761-766.
|
| 26 |
Wang J, Zhou Y, Lu J, et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognositic biomarkers for laryngeal squamous cell carcinoma [J]. Med Oncol, 2014, 31(9): 148.
|
| 27 |
Xu N, Chen F, Wang F, et al. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study [J]. Tumour Biol, 2015, 36(10): 7659-7665.
|